Literature DB >> 3985844

Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells.

P A Campochiaro, B M Glaser.   

Abstract

The presence of blood or serum in the vitreous cavity has been associated with the formation of cellular membranes in proliferative vitreoretinopathy and after penetrating ocular trauma. Retinal pigment epithelial (RPE) cells are an important component of these membranes. For RPE cells to effectively spread throughout the vitreous cavity and form contractile membranes, cell migration must occur. Serum has been shown to initiate RPE cell migration. Fibronectin (FN), a glycoprotein found in serum, stimulates RPE cell migration but accounts for only part of the stimulatory effect of serum. We report that another serum component, platelet-derived growth factor (PDGF), also stimulates RPE cell migration. Furthermore, the effect of PDGF and FN are additive and together probably account for a large part of the chemotactic activity found in serum.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985844     DOI: 10.1001/archopht.1985.01050040118034

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  28 in total

1.  Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor.

Authors:  A Ando; M Ueda; M Uyama; Y Masu; S Ito
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

Review 2.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

3.  Generation and characterization of ABBV642, a dual variable domain immunoglobulin molecule (DVD-Ig) that potently neutralizes VEGF and PDGF-BB and is designed for the treatment of exudative age-related macular degeneration.

Authors:  Kun Ding; Lucia Eaton; Diana Bowley; Matthew Rieser; Qing Chang; Maria C Harris; Anca Clabbers; Feng Dong; Jikui Shen; Sean F Hackett; Debra S Touw; Jacqueline Bixby; Suju Zhong; Lorenzo Benatuil; Sahana Bose; Christine Grinnell; Gregory M Preston; Ramesh Iyer; Ramkrishna Sadhukhan; Susan Marchie; Gary Overmeyer; Tariq Ghayur; Deborah A van Riet; Shibo Tang; Peter A Campochario; Jijie Gu
Journal:  MAbs       Date:  2017 Feb/Mar       Impact factor: 5.857

4.  Macrophage modulation of retinal pigment epithelial cell migration and proliferation.

Authors:  B Kirchhof; E Kirchhof; S J Ryan; J F Dixon; B E Barton; N Sorgente
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

5.  Regulation of fibronectin-EDA through CTGF domain-specific interactions with TGFβ2 and its receptor TGFβRII.

Authors:  Rima Khankan; Noelynn Oliver; Shikun He; Stephen J Ryan; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-07       Impact factor: 4.799

6.  The development of vitreous membranes and retinal detachment induced by intravitreal carbon microparticles.

Authors:  P Algvere; I H Wallow; B Martini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

7.  Origin of simple glial epiretinal membranes in an animal model.

Authors:  J S Lean
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

8.  Antifibrotic and uveitogenic properties of gamma interferon in the rabbit eye.

Authors:  L M Hjelmeland; J W Li; C A Toth; M B Landers
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

9.  The chemoattractant activity of the vitreous to human scleral fibroblasts following retinal detachment and proliferative vitreoretinopathy.

Authors:  N Wilson-Holt; P Khaw; F Savage; I Grierson
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

10.  Dexamethasone and indomethacin attenuate cryopexy. Induced breakdown of the blood-retinal barrier.

Authors:  J H Stahl; D B Miller; B P Conway; P A Campochiaro
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.